Albert Siu, MD, MSPH; Heather Allore, PhD, MS, MA; Darryl Brown, PhD, MPA; Susan T. Charles, PhD; Matthew Lohman, PhD, MHS
In October 2018, the National Institutes of Health convened the Pathways to Prevention (P2P) Workshop: Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention to assess the available evidence on long-term use of drug therapies to prevent osteoporotic fractures and identify research gaps and needs for advancing the field. This final report summarizes the panel's findings and recommendations.
Carolyn J. Crandall, MD, MS
In this issue, Siu and colleagues summarize the October 2018 National Institutes of Health Pathways to Prevention Workshop on long-term drug therapy to prevent osteoporotic fracture, and Fink and colleagues report the systematic review that informed the workshop. The editorialist discusses the important gaps in our understanding of the long-term treatment of osteoporosis, where “long-term” is defined as longer than 3 years.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use